chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen right gland under ear, causing facial swelling, pain on the right side of face, and earache. Went to Urgent Care on Monday morning 6/13 and was given antibiotics which started to help relieve swelling within 24 hours.
This spontaneous report as received from a registered nurse refers to unspecified patients of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. It was reported that from 14-MAR-2016 to 16-MAR-2016, (Merck) VARIVAX (lot # reported as L041205, expiration date 30-OCT-2017; lot # reported as L045956, expiration date 17-OCT-2017; lot # L025208, expiration date 07-JUL-2017; lot # reported as L041205, expiration date 02-OCT-2017) were improperly exposed to -12.97 centigrade degree for 9.5 hours and -12.59 centigrade degree for 9.75 hours and -10.79 centigrade degree for 14 hours. Then, on unspecified dates after 16-MAR-2016 (in 2016), the patients were vaccinated with the improperly stored vaccine (dose and route not reported). There were no known adverse effects. This is one of several reports received from the same source. Additional information has been requested.
This case was reported by a physician and described the occurrence of injection site soreness in a 15 year old male subject who was inadvertently vaccinated with Infanrix for prophylaxis. On 6/14/05, the subject inadvertently received a dose of Infanrix in an unspecified arm (dose and lot number not provided) rather than the intended administration of TD. Infanrix is not recommended for immunizing individuals 7 years of age or older. On 6/14/05, the subject also received injections of Hep-B and MMRII in the "other arm". At an unspecified time following the administration of Infanrix, on 6/14/06, the subject experienced injection site soreness at the site of the Infanrix injection. The immunization series with Infanrix was discontinued. The injection site soreness was ongoing at the time of reporting, 6/15/05.
Two days after the dose (on the 14th) my period began suddenly three days early, which is unheard of for me. I also developed a migraine on the 14th that lasted for a total of 9 days. This is also unheard of for me.
presented with acute chest pain on 6/6/21. He had an EKG that showed ST elevation, that resolved on follow up testing. He had an ECHO that did not show an acute disease. Troponin started at 28 pg/mL, peaked to 1911 pg/mL on 6/7/21 and came down to 782 pg/mL  on 6/8/21 prior to discharge. He was treated with ibuprofen. The chest pain resolved and he was sent home with outpatient follow up on ibuprofen.  BNP remained within normal limits. He underwent full viral testing including Lyme antibodies as there was a concern for a tick. The only positive test was the Rhinovirus/Enterovirus NP PCR. There were no signs of viral illness. No coughing, congestion, rash, joint pain, N/V/D.
2nd covid shot given today 9/2/21. Within 5 minutes or less of giving vaccine. Patient was waiting in waiting room area of pharmacy in chair and mother called me over because she said  the patient arched his back and lost consciousness for a few seconds and slid out of the chair onto the waiting room floor.  When I arrived over to the patient he was conscious and awake and he said he felt dizziness before losing consciousness. He also said he was really nervous/anxious about getting 2nd shot. He said he gets feeling of throwing up when he gets anxious in the past and it was very similar to that. He was sweating more than normal but said he felt much better. I gave the patient a glass of water and had him stay seated on the floor for 10-15  minutes post incident to make sure he felt ok before standing up. Mother declined 911 being called due to patient feeling better and decided to call primary pediatrician instead.
When I walk I get wobbly, feel like woozy and don't feel well; When I walk I get wobbly, feel like woozy and don't feel well; This is a spontaneous report from a contactable nurse. A 93-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6200), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization (at the age of 93-year-old). Medical history included high blood pressure, hypothyroidism and blood cholesterol. Concomitant medication included levothyroxine sodium (SYNTHROID). On an unspecified date, when patient walk he got wobbly, feel like woozy and don't feel well. The outcome of the events was unknown.  No follow up attempts are possible. No further information is expected.
sore arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 61 year-old male patient received bnt162b2 (BNT162B2), administration date Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "sore arm".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Half hour after vaccine complained of itchy chest, shoulders, back, arms, ears and neck.  within 1 hour you blotchy non-raised rash to chest, front of shoulders, back.   Seen in Urgent Care rash traveled down arms. Treated with Zyrtec, Pepcid. At bedtime Benadryl and Zyrtec x 7 addition days.  1/15 doing better, still has rash on neck and arms.
I RECEIVED THE VACCINE 10-11-22 IN THE AFTERNOON.  I WOKE UP ABOUT 12 OR 1 AM IN EXTREME PAIN.  MY CERVICAL SPINE WAS ON FIRE, MUSCLES HORRIBLY TAUT AND A KILLER AND I DO MEAN KILLER MIGRAINE.
Ataxia - onset 9/3/2011, lasted 3-4 days then resolved. No treatment frequent falls, seemed "drunk", walked in circles. MMR & varicella given 9 day prior to onset.
12/09/2021  The patient presents with arm pain. 24 year old female presents to ED complaining of chill and arm pain, after receiving her second COVID-19 vaccination shot. Pt took Tylenol for her symptoms, with no relief. Pt denies chest pain, sob, fever, diarrhea.  The onset was 1  days ago.  The course/duration of symptoms is constant.  Location: left. The character of symptoms is pain.  The degree at onset was moderate.  The degree at present is moderate.  Risk factors consist of COVID-19 vaccination.   Associated symptoms: chills, arm pain, denies chest pain, denies abdominal pain and denies nausea.
broke out in a rash on my neck and face; blisters inside my bottom lip; rash on my neck now looks like a burn / same wtih my cheeks; experienced chills; fever; body aches; This case was reported by a consumer and described the occurrence of chills in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included drug allergy.   On an unknown date, the patient received Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced chills, fever, general body pain, rash, lip blister and red rash. On an unknown date, the outcome of the chills, general body pain and lip blister were recovered/resolved and the outcome of the fever was unknown and the outcome of the rash and red rash were not recovered/not resolved.   It was unknown if the reporter considered the chills, fever, general body pain, rash, lip blister and red rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The age group was not reported but it was selected as adult as per the vaccine indication. The received Shingrix and experienced chills, fever and body aches. That lasted 24 hours. The patient broke out in a rash on neck and face and blisters inside my bottom lip.  The blisters are gone, however it was day four of dealing with symptoms.  The rash on my neck looks like a burn, and the same with my cheeks.  The patient was allergic to a few medicines and had reactions to some, after stopping taking the medication. The patient cannot think of anything else that had done that would had caused this to happen to my face and neck.
HUMIRA HAD BAD INTERACTION TO COVID-19 VACCINE/RED SPOTS ALL OVER LEGS/ANKLES SWELLING; HUMIRA HAD BAD INTERACTION TO COVID-19 VACCINE/RED SPOTS ALL OVER LEGS/ANKLES SWELLING; HUMIRA HAD BAD INTERACTION TO COVID-19 VACCINE/RED SPOTS ALL OVER LEGS/ANKLES SWELLING; This spontaneous case was reported by a consumer and describes the occurrence of DRUG INTERACTION (HUMIRA HAD BAD INTERACTION TO COVID-19 VACCINE/RED SPOTS ALL OVER LEGS/ANKLES SWELLING), JOINT SWELLING (HUMIRA HAD BAD INTERACTION TO COVID-19 VACCINE/RED SPOTS ALL OVER LEGS/ANKLES SWELLING) and RASH MACULAR (HUMIRA HAD BAD INTERACTION TO COVID-19 VACCINE/RED SPOTS ALL OVER LEGS/ANKLES SWELLING) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Ulcerative colitis.    No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) pre-filled pen. On an unknown date, the patient experienced DRUG INTERACTION (HUMIRA HAD BAD INTERACTION TO COVID-19 VACCINE/RED SPOTS ALL OVER LEGS/ANKLES SWELLING), JOINT SWELLING (HUMIRA HAD BAD INTERACTION TO COVID-19 VACCINE/RED SPOTS ALL OVER LEGS/ANKLES SWELLING) and RASH MACULAR (HUMIRA HAD BAD INTERACTION TO COVID-19 VACCINE/RED SPOTS ALL OVER LEGS/ANKLES SWELLING). At the time of the report, DRUG INTERACTION (HUMIRA HAD BAD INTERACTION TO COVID-19 VACCINE/RED SPOTS ALL OVER LEGS/ANKLES SWELLING) outcome was unknown and JOINT SWELLING (HUMIRA HAD BAD INTERACTION TO COVID-19 VACCINE/RED SPOTS ALL OVER LEGS/ANKLES SWELLING) and RASH MACULAR (HUMIRA HAD BAD INTERACTION TO COVID-19 VACCINE/RED SPOTS ALL OVER LEGS/ANKLES SWELLING) was resolving.            No concomitant medication was reported.   Treatment information was not provided. This case was identified as part of a retrospective clean-up activity where certain emails received in the mailbox were missed to be booked-in.
Client received Influenza Virus vaccine at 12:00 pm 10/31/2008.  Client returned to clinic-12:20pm 10/31/08 with c/o throat tightness and enlarged tongue upon exam, noted enlarged tongue.  Pharynx open. Lungs CTA bilaterally no wheezing. Epipen 1:1000 .3mg given in L anterolateral thigh at 12:23 p.m....  Paramedics arrived at 12:25 p.m client reported felt better after Epipen. Client sent to ER via ambulance for further evaluation at 12:30 pm 10/31/2008.
R&L shoulders sore. Hands hurting R&L. MOPM gave Benadryl at HS. Next am shoulders OK but hands hurt and unable to make a complete fist. Advised to see doctor.
The COVID-19 vaccine administered through vaccine administrator,  Health Authority, between June 25 and July 30 came from the lot number 039K20A.  It was discovered that this particular lot was beyond its frozen expiration date by five (5) up to forty (40) days.  A case was opened with Moderna (Case #: MOD21-126790).  Please refer to this case number if you would like to contact Moderna directly.  Moderna confirmed that the vaccine doses administered maintained the activity necessary to protect against the COVID-19 virus.  Moderna also confirmed there is no danger to anyone's health from receiving a vaccine past its frozen expiration date.  No adverse reactions were identified.
I had flashing light in my left eye and I had developed floater in my eye. I was inoculated under my left arm. I felt a pressure and pain in my left eye. I made an appointment with an opthamologist and he said everything was fin. I started to see bright flashign in my left eye and floaters. I developed pressure and pain in that eye as well. My lymph nodes were also swollen under both arms. The doctor advised everything was normal. He completed an MRI, dilated my pupils and completed a vision exam. The pain did subside in my eyes but the floater and flashing lights are  still there. I was advised this was due to my age and there was no cure. The doctor indicated he did not believe this was related to the vaccine.
Severe nausea after approx. 24 hours of the injection Fatigue Armpit pain and swelling on the side of body where vaccine was injected: approx. 5 days after injection
Patient is a 95 y.o. male who presented from home on is a 95 y.o. male who presented from home on 9/12/2023 with confusion. Patient recently diagnosed with COVID was receiving Paxlovid as outpatient.  Was found to be hypoxic on presentation to the hospital with fever.  Chest x-ray revealed minimal basilar opacity.  Patient was started on dexamethasone and remdesivir due to hypoxia with significant improvement in his symptoms.  Was afebrile and asymptomatic on the day of discharge.  Based on discussion with wife at the bedside they elected to be discharged today.  Patient will be discharged with dexamethasone.  Received 2 days of remdesivir and 2 days of Paxlovid prior to hospitalization.  Based on discussion with clinical pharmacist Paxlovid no longer indicated.         Assessment and Plan   Acute metabolic toxic encephalopathy -Presented with aphasia.  Was found to be febrile on presentation.   -Etiology in setting of acute medical illness  -Metabolic and infectious work-up otherwise unremarkable  -Head CT unremarkable.  CTA head with severe stenosis of proximal left posterior cerebral artery moderate to severe stenosis and to branch of left middle cerebral artery -Patient with no other accompanying drug interactions while taking Paxlovid.  He is currently back to his baseline answering all questions appropriately. -Neurologic exam unremarkable -Delirium precautions, sleep hygiene. -PT OT consulted patient will be discharged home with home health     COVID-19 infection Acute respiratory failure with hypoxia - Presented with: Confusion, aphasia - Symptom onset: 9/10 - Positive COVID-19: 9/10 at home - Vaccination status: Vaccinated with Pfizer with last dose 11/2021 x3 - CXR on admission showed minimal by lateral basilar opacity - Oxygen status: O2 sat 88% on room air, placed on nasal cannula - Decadron: Initiated - Remdesivir: Initiated.  -Dry lung strategy.  Received spot diuresis with Lasix IV -Lung exam within normal on the day of discharge. -No current indication for antibiotic therapy. -Pulmonary hygiene   Fever -In setting of COVID-19 infection. -No clinical concern for bacterial pneumonia.  Given onset of symptoms was on Sunday.  Chest x-ray findings as well as physical exam -Currently afebrile -Continue treatment as above   CKD 3B -Baseline creatinine appears to be 1.7?1.9 -Creatinine on admission 1.78. -Continue to monitor urinary output and creatinine. -Renally dose for GFR less than 30. Hypertension -Blood pressure controlled currently -Takes amlodipine, lisinopril, and metoprolol in the home setting. -Continue his home regimen.   Hyperlipidemia -Resume statin   OSA -CPAP ordered.   Hx of TIA -Per review of chart -Continue home ASA.
Information has been received from a physician assistant concerning a 14 year old patient who was vaccinated when she was a child with three separate doses of RECOMBIVAX HB (manufacturer unknown), the first dose was given on 24-JUL-1996. T he physician assistant reported that the patient failed to have a positive titer after receiving the 3 doses listed above. On 16-JUL-2010, the titer was drawn and the result was negative, subsequently on 07-AUG-2010, the patient was vaccinated with another dose of RECOMBIVAX HB (Lot#: not reported). No adverse effect was reported. The patient sought unspecified medical attention. At the time of the repot, the patient's outcome was unknown. Additional information has been requested.
Patient had swelling and redness that spanned from elbow to armpit of the vaccinated arm (right arm). She also had fever, chills and fatigue. I advised her to follow up with a physician, as when she called (11/20), she had already been having the reaction for 2-3 days and it didn't seem to be improving at all. She did finally go in today (11/23) and the physician believes that she has cellulitis. However, of note, she also told me that she had a similar reaction to a Shingrix reaction in the past.
When patient got a flu shot it seems to build my immune system against cold, patient got them but not severe; Initial information was received on 08-Nov-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case involves a patient of unknown age and when patient got a flu shot it seems to build patient's immune system against cold, patient got them but not severe (nasopharyngitis), while patient was treated with influenza vaccine.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was not reported.  On an unknown date, the patient received influenza vaccine [lot number: unknown and expiration date: unknown] at an unknown dose via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, when patient got a flu shot it seems to build patient's immune system against cold, patient got them but not severe (nasopharyngitis).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the events was unknown.  There will be no information available regarding batch number in this case.
W/in 1 hrs of HIB, rash on back, 2-3 hrs lesion on chin-vesicular; Following AM 21JUN t100, rash on trunk, extremities, face; PM 21JUN swollen wrists & ankles;
Myalgia CHILLS Narrative:  WOULD HAVE MISSED WORK BUT COULDNOT BE ABSENT FROM PATIENT CARE  Other Relevant History:
Myalgia, Arthralgia, Fever, same day at around 8pm (fever 102., chills, and muscle/joint pain, sore arm). lingered for another 24 hours Narrative:
A health professional reported the spontaneous non-serious event of FLUMIST went into the eye and on the cheek involving a six-year-old male child. The reporter stated she administered FLUMIST to a child and he jerked his head and FLUMIST went into his eye and on his cheek. No medical attention or other symptoms were reported. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Patient received booster injection from a vial that was out overnight- past the 6 hour time frame.
Decreased heart rate 40-50 five days after getting vaccine; This is a spontaneous report from a contactable nurse. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the right arm on 17Jul2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included system lupus erythematous , non-celiac gluten sensitivity and GERD (gastroesophageal reflux disease). The patient previously took salbutamol (ALBUTEROL) and hydroxychloroquine sulfate (PLAQUENIL) and experienced drug allergy for both on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included colecalciferol (VITAMIN D3) from unknown date and for unknown indication. On 22Jul2021 the patient experienced decreased heart rate 40-50 five days after getting vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of the event. The clinical outcome of the event decreased heart rate 40-50 five days after getting vaccine was resolving at the time of this report.   The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
he recently broke his leg; This is a spontaneous report from a contactable consumer (reported as caregiver) via Medical Information Team and Pfizer-sponsored program COVAX US support. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration were not reported), via an unspecified route of administration on 22Mar2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient recently broke his leg on an unspecified date after the first dose. He had a leg surgery last week in Apr2021 and was prescribed a blood thinner. Patient wanted to know if it was okay for him to take the medication before or after the second dose of vaccine. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
When I received my vaccination the nurse mentioned  there was a little blood.  One week to the day I started experiencing an itch around the injection sight. I was woken a few times thru the evening itching my arm. In the morning the area of my arm that received  the injection was warm to touch, swollen and it looked like I was punched in the arm. The red bruise that appeared  was round and the diameter of an orange. This lasted till Monday. I took 1 Benadryl tablet Monday evening and went to sleep   Woke up Tuesday morning and the redness, itch and swelling were gone
Symptoms include, hot flashes. palpitations and shortness of breath five minutes after vaccine administration. Patient was given oxygen and Claritin 45 minutes after.  Patient was sent to hospital for further monitoring after an hour of administration.
Over the first 24 hours after receiving vaccine, pt developed swelling and redness in the L arm with some edema. Area was painful, but denies fever,chills, SOB, or chest pain. Took Benadryl before OV. Gave Decadron in the office.
Patient arrived to ED with C/O vision changes and dizziness after vaccine on Saturday (unknown) patient was transferred to Main campus for Occipital Stroke at neuro facility., This facility did not give the vaccine
tiredness and achiness began at 6:30pm 3/15/22, along with swollen pectoral muscle. All over achniness and tiredness worsened, along with swollen pectoral muscle, rapid heart rate and breathing, and chills began late that evening around midnight and lasted through 7am on 3/17/22. Achiness, chills, rapid heart rate and breathing subsided at that time. As of 11:15am on 3/17/22, pectoral muscle is still very swollen and painful and tiredness persists.
Patient was asymptomatic and was vaccinated on 1/22/2021.  A facility caregiver tested positive for COVID, so patient was tested and received results on 1/27/2021 indicating positive for COVID-19.  Patient expired early morning of 2/1/2021, still completely asymptomatic.  Patient's physical condition had been fairly stable for the previous few years.
Pt. recieved varicella less than 4 weeks from MMR.  MMR given on 4-2-07 and Varicellan given on 4-18-07.
Severe headache, body aches, cold sweats, chills, and muscle spasms. At a week out I continue to have body aches.
Patient reports experiencing intense prolonged arm soreness/discomfort for the past month following receiving this vaccination. Patient states it is now difficult to lift or move the arm and the soreness has not improved at all in the last month. Patient also received a Pfizer Bivalent COVID-19 booster on the same day in the opposite arm, and does not report any prolonged adverse effects related to this vaccine. Patient was referred to their primary care provider for further evaluation/management.